iSTAR Medical

OverviewSuggest Edit

iSTAR Medical develops ophthalmic implants from biomaterials. The Company is focused on the development of novel ophthalmic implants for patients with glaucoma.

TypePrivate
Founded2009
HQWavre, BE
Websiteistarmed.com

Recent NewsAll News

Latest Updates

Employees (est.) (Oct 2019)17(+14%)

Key People/Management at iSTAR Medical

Cecile Roy

Cecile Roy

R&D Manager
Pierre Geens

Pierre Geens

RA/QA/Clinical Affairs Manager
Show more

iSTAR Medical Office Locations

iSTAR Medical has an office in Wavre
Wavre, BE (HQ)
6 Avenue Sabin
Show all (1)

iSTAR Medical Financials and Metrics

Summary Metrics

Founding Date

2009

iSTAR Medical total Funding

$61.2 m

iSTAR Medical latest funding size

$44.14 m

Time since last funding

a month ago

iSTAR Medical investors

iSTAR Medical's latest funding round in September 2019 was reported to be $44.1 m. In total, iSTAR Medical has raised $61.2 m
Show all financial metrics

iSTAR Medical Online and Social Media Presence

Embed Graph

iSTAR Medical News and Updates

iSTAR Medical grabs Series C

Belgium-based iSTAR Medical SA, a developer of ophthalmic implants for the treatment of glaucoma, has raised 40 million euros in Series C financing. LSP and Gimv led the round with participation from Earlybird, BNP Paribas Fortis Private Equity, Capricorn Partners, Walloon Region Investment Fund and…

iSTAR Medical Announces EUR 40m Series C Financing

WAVRE, Belgium, Sept. 5, 2019 /PRNewswire/ -- iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced the completion of a €40m Series C financing. The financing was led by healthcare specialist funds LSP and...

iSTAR Medical Blogs

iSTAR Medical announces EUR 40m Series C Financing

To accelerate development and commercialisation of innovative Glaucoma MIGS device, MINIjectTM WAVRE, Belgium — 5 September 2019:  iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced the completion of a €40m Series C …

iSTAR Medical’s MINIject shows consistent results at 18-month follow-up in first-in-human trial (STAR-I)

WAVRE, Belgium — 10 July 2019: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced consistent 18-month results of the first-in-human, micro-invasive glaucoma surgery (MIGS) STAR-I trial for the MINIjectTM device in a …

iSTAR Medical’s MINIject maintains exceptional results in first-in-human trial one year post-surgery (STAR-I)

WAVRE, Belgium — 19 December 2018: iSTAR Medical SA, a private medical device company developing novel ophthalmic implants for the treatment of glaucoma, today announced exceptional one-year results of the first-in-human, micro-invasive glaucoma surgery (MIGS) STAR-I trial, for the MINIjectTM device…

OIS@AAO

25 October, 2018 - Chicago, IL, USA The post OIS@AAO appeared first on iSTAR Medical.

iSTAR Medical Frequently Asked Questions

  • When was iSTAR Medical founded?

    iSTAR Medical was founded in 2009.

  • Who are iSTAR Medical key executives?

    iSTAR Medical's key executives are Cecile Roy and Pierre Geens.

  • How many employees does iSTAR Medical have?

    iSTAR Medical has 17 employees.

  • Who are iSTAR Medical competitors?

    Competitors of iSTAR Medical include ViewRay, Intersect ENT and Pressure BioSciences.

  • Where is iSTAR Medical headquarters?

    iSTAR Medical headquarters is located at 6 Avenue Sabin, Wavre.

  • Where are iSTAR Medical offices?

    iSTAR Medical has an office in Wavre.

  • How many offices does iSTAR Medical have?

    iSTAR Medical has 1 office.